Shareholders Alert: Join Class Action Against PROCEPT BioRobotics Corporation for Potential Recovery

Class Action Suit Against PROCEPT BioRobotics

Shareholders of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) are being urged to join a class action lawsuit as part of an effort to recover their financial losses. The Gross Law Firm has recently disseminated a notice targeting all investors who purchased stock within the designated class period, which spans from February 28, 2024, to February 25, 2026.

Background on PROCEPT BioRobotics

PROCEPT BioRobotics is a company engaged in developing advanced medical technologies for various surgical procedures. However, recent allegations against the company have raised concerns among investors. According to the lawsuit, during the specified class period, PROCEPT allegedly made several misleading statements about its financial performance, particularly related to its handpiece sales and revenue.

Allegations Against the Company

The lawsuit outlines significant discrepancies in the company’s reported sales figures that supposedly resulted from an undisclosed discount program. This program was designed to encourage bulk orders from customers, creating an illusion of high sales volumes that didn't align with actual demand. The key allegations include:

1. Manipulation of Sales Data: The complaint suggests that PROCEPT inflated its reported U.S. handpiece unit sales by utilizing an extensive discount program, thereby misleading shareholders about true company performance.
2. Overstated Revenues: The alleged discount program allegedly distorted the company’s revenue figures, pulling forward sales at the potential expense of future earnings.
3. Inventory Surplus: Evidence indicates that due to these practices, PROCEPT's customers accumulated a surplus of more than 10,000 handpiece units, resulting in unsold inventory.
4. Failure to Meet Projections: The company was unable to reach its operational targets for 2025, casting doubt on the accuracy of prior financial forecasts which led to shareholder losses.

Deadlines and Next Steps for Shareholders

The Gross Law Firm is calling for affected shareholders not to delay in their response. The cutoff date to register as a lead plaintiff in this class action is set for September 22, 2026, which underscores the urgency for those who wish to be part of the suit. To assist shareholders, the firm will enroll participants in specialized portfolio monitoring software, which will keep them informed on the progress of the case and any potential settlements.

Interested shareholders can register through the following link: Registration Here.

Why Choose The Gross Law Firm?

The Gross Law Firm is recognized nationally for its class action litigation efforts. Their mission focuses on safeguarding investor rights and addressing corporate malpractices that lead to investor losses. The firm emphasizes that being appointed as a lead plaintiff is optional and that participation in the class action carries no financial obligation for shareholders.

For more information or specific inquiries, shareholders are encouraged to reach out directly to The Gross Law Firm via their official contact details, including phone and email, which are provided in their press release.

In summary, shareholders of PROCEPT BioRobotics Corporation have grounds to seek compensation for alleged financial misconduct. Those impacted during the class period are urged to act quickly and explore their options for recovery to ensure their rights are protected.